When was Biosynex founded?

Biosynex was founded in 2005 and raised its 1st funding round 10 years after it was founded.

Where is Biosynex located?

Biosynex is headquartered in Strasbourg, France.

How many employees does Biosynex have?

As of Aug 31, 2026, the latest employee count at Biosynex is 219.

Is Biosynex a funded company?

Biosynex is a funded company, having raised a total of $2.83M across 2 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Nov 06, 2015.

When was the latest funding round of Biosynex?

Biosynex's latest funding was a $***** Conventional Debt round on Jul 18, 2016, with participation from 1 investor.

Biosynex - 2026 Company Profile, Team & Funding

Company Details

Biosynex (previously DIMA) is the manufacturer and provider of rapid membrane tests in the in-vitro diagnostic market. Its professional diagnostic products include Rapid diagnostic tests (RDTs) to detect an infection (HIV, malaria, mononucleosis, tonsillitis), an immune status (tetanus immunity), a physiological situation (pregnancy), an acute pathological situation (rupture of fetal membranes, myocardial infarction) or the presence of drugs in urine or saliva Blot tests (Western Blot or immunoblot) to indicate the presence or absence of antibodies and Real-time PCR (qPCR) enables the quantitative measure of DNA and ARN molecules. It also develops self-diagnostic tests for pregnancy, drug testing, blood pressure and glucose monitoring. It also provides oral care, reading glasses and foot care products.

Key Metrics

Founded Year

2005

Location

Strasbourg, France

Stage

Public

Total Funding

$2.83M in 2 rounds

Latest Funding Round

Conventional Debt, Jul 18, 2016, $*****

Investors

Bpifrance & 2 more

Employee Count

219 as on Aug 31, 2026

Investment & Acquisitions

ProciseDx & 9 more

Exit Details

Public

View Biosynex's full profile

Biosynex got listed on Mar 21, 2011.

Click here to take a look at Biosynex's IPO in detail

Biosynex has raised a total funding of $2.83M over 2 rounds. Its first funding round was on Nov 06, 2015. Its latest funding round was a Conventional Debt round on Jul 18, 2016 for $*****. 1 investor participated in its latest round. Biosynex has 3 institutional investors.

Here is the list of recent funding rounds of Biosynex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 18, 2016	3298399	Conventional Debt	8880606	5948248	3853906	3708564
Nov 06, 2015	1176015	Post IPO	2927182	7132140	9791255	6192470

Access funding benchmarks and valuations. Sign up today!

View details of Biosynex's funding rounds and investors

The founders of Biosynex is Thierry Paper.

Here are the details of Biosynex's key team members:

Thierry Paper: Founder & CEO of Biosynex.

View details of Biosynex's Founder profiles and Board Members

Biosynex's employee count trend

Biosynex has 219 employees as of Aug 26. Here is Biosynex's employee count trend over the years:

Uncover Biosynex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Biosynex has made 2 investments in companies including ProciseDx and ProciseDx. Biosynex has also acquired 8 companies including ProciseDx and Chembio.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 12, 2023	Acquisition	ProciseDx	2018	San Diego (United States)
Jan 31, 2023	Acquisition	Chembio	1986	Medford (United States)
Dec 21, 2022	Acquisition	Medkoncept	2017	Hellerup (Denmark)